Mathematical modeling of ischemic stroke
https://doi.org/10.14412/2074-2711-2019-4-38-43
Abstract
Objective: to determine the prognostic value of the indicators of fluid and electrolyte balance in the acutest period of severe ischemic stroke (IS).
Patients and methods. A total of 150 patients with severe IS of various locations and pathogenetic subtypes were examined. The impact of plasma osmolarity or sodium levels on the course and prognosis of IS was studied on day 1 of the disease.
Results and discussion. It has been established that in patients with severe IS, the most common type of fluid and electrolyte imbalance is hyperosmolar hypernatremic syndrome that develops at the onset of severe IS, serves as a factor for poor outcome, and is accompanied by high mortality. The rate of fatal outcomes in hypoosmolar syndromes is higher than that in normal plasma osmolarity, but significantly lower than that in hyperosmolar syndromes. Cerebral salt wasting (CSW) is associated with a higher mortality rate than syndrome of inappropriate antidiuretic hormone secretion (SIADH), which confirms a worse prognostic value in hypovolemia than in normo- and hypervolemia. The development of diabetes insipidus at the onset of IS reflects the degree of brainstem structural destruction and, accordingly, is associated with the highest rate of fatal outcomes. The cardioembolic pathogenetic subtype of IS is characterized by a more severe course and a higher probable mortality rate in both hypoosmolar and normosmolar conditions.
Conclusion. Impaired fluid and electrolyte homeostasis is of significant prognostic value for the outcome of IS. In this case, the leading role is played by the hyperosmolar hypernatremic syndrome, in which the probability of a fatal outcome is highest and there is a need for continuous patient health monitoring and high-speed decision-making aimed to correct this condition. Therapeutic policy for diabetes insipidus depends on the duration of IS. The risk for fatal outcome in the cardioembolic pathogenetic subtype of IS is higher than that in atherothrombotic stroke, at any plasma osmolarity and sodium levels.
About the Authors
V. I. ErshovRussian Federation
6, Sovetskaya St., Orenburg 460000;
140B, Pobeda Prospect, Orenburg 460000
A. N. Chirkov
Russian Federation
6, Sovetskaya St., Orenburg 460000;
23, Aksakov St., Orenburg 460018
A. P. Gonchar-Zaykin
Russian Federation
6, Sovetskaya St., Orenburg 460000
S. N. Lyashchenko
Russian Federation
6, Sovetskaya St., Orenburg 460000
T. Yu. Lozinskaya
Russian Federation
6, Sovetskaya St., Orenburg 460000
N. V. Gumalatova
Russian Federation
6, Sovetskaya St., Orenburg 460000;
140B, Pobeda Prospect, Orenburg 460000
G. E. Kuznetsov
Russian Federation
6, Sovetskaya St., Orenburg 460000;
140B, Pobeda Prospect, Orenburg 460000
L. R. Tenchurina
Russian Federation
6, Sovetskaya St., Orenburg 460000;
140B, Pobeda Prospect, Orenburg 460000
References
1. Gafarov VV, Gromova EA, Panov DO, et al. Social support and stroke risk: an epidemiological study of a population aged 25–64 years in Russia/Siberia (the WHO MONICA-psychosocial program). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(1):12-20. (InRuss.) doi: 10.14412/2074-2711-2019-1-12-20
2. Gusev EI, Skvortsova VI, Stakhovskaya LV. The problem of stroke in the Russian Federation: the time of active joint actions. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2007;107(6):4-10. (In Russ.)
3. Gusev EI, Martynov MYu, Kamchatnov PR, et al. Cerebral stroke. Consilium Medicum. 2014;16(12): 13-7. (In Russ.)
4. Klochikhina OA, Stakhovskaya LV. Analysis of epidemiological indicators of stroke according to territorial and population registers 2009-2012. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;114(6):63-9. (In Russ.)
5. Stakhovskaya LV, Klochikhina OA, Bogatyreva MD, et al. Epidemiology of stroke in Russia based on the results of the territorial and population register (2009-2010). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113(5-1):4-10. (InRuss.)
6. Favate AS. Epidemiology of ischemic stroke. Neurol Clin. 2016 Nov;34(4):967-980. doi: 10.1016/j.ncl.2016.06.013.
7. Kulesh AA, Kaileva NA, Gorst NKh, et al. A relationship between the integrated assessment of magnetic resonance imaging markers for cerebral small vessel disease and the clinical and functional status in the acute period of ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1): 24-31. (In Russ.) doi: 0.14412/2074-2711-2018-1-24-31
8. Filimonova PA, Volkova LI, Alasheev AM, et al. In-hospital stroke in patients after cardiac surgery or invasive interventions. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(4):38-45. (In Russ.) Doi: 0.14412/2074-2711-2017-4-38-45
9. Widimsky P. What is new in ischemic stroke? Dialogues in Cardiovascular Medicine. 2017; 22(3):25-26.
10. Савин ИА, Попугаев КА, Ошоров АВ и др. Несахарный диабет в остром периоде субарахноидального кровоизлияния. Анестезиология и реаниматология. 2007;(2): 57-62. [Savin IA, Popugaev KA, Oshorov AV, et al. Diabetes insipidus in the acute period of subarachnoid hemorrhage. Anesteziologiya i reanimatologiya. 2007;(2):57-62. (InRuss.)].
11. Shchekochikhin DYu, Kozlovskaya NL, Kopylov FYu, et al. Hyponatremia: a clinical approach. Terapevticheskii arkhiv. 2017;89(8): 134-40. (In Russ.)
12. Balasubramanian A, Flareau D, Sourbeer J. Syndrome of Inappropriate Antidiuretic Hormone Secretion. Hospital Physician. 2007 Apr;39:33-6.
13. Kembuan MAHN, Sekeon SAS. Electrolyte disturbances among acute stroke patients in Manado, Indonesia. GJMEDPH. 2014;3(1).
14. Savin IA, Goryachev AS. Vodno-elektrolitnye narusheniya v neiroreanimatsii [Water-electrolyte disorders in neuro-resuscitation]. Moscow; 2015.
15. Peri A. Parenti G, Pirozzi N, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Endocrinol Invest. 2010 Oct;33(9):671-82. doi: 10.1007/BF03346668. Epub 2010 Oct 8.
16. Rost N, Biffi A, Cloonan L, et al. Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke. Stroke. 2012 Feb; 43(2):441-5. doi: 10.1161/STROKEAHA.111.629212. Epub 2011 Nov 23.
17. Sherlock M, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol. 2010 Jun;162 Suppl 1:S13-8. doi: 10.1530/EJE-09-1057. Epub 2010 Feb 17.
18. Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir (Wien). 2003 Oct; 145(10):851-60; discussion 860.
19. Vinay PA, Daneault S, Seck M, et al. SIADH syndrome related to the dying process. Medecine Palliative. 2011;10(3):137-143.
20. Yanishevskii SN. Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):116-20. (In Russ.) doi: 10.14412/2074-2711-2018-3-116-120
21. Chirkov AN, Ershov VI. Prognostic value of water-electrolyte disorders in the acute period of severe ischemic stroke. Anesteziologiya i reanimatologiya. 2016; 61(6):404-7. (InRuss.)
22. Kim YD, Hong HJ, Cha MJ, et al. Determinants of infarction patterns in cardioembolic stroke. Eur Neurol. 2011;66(3):145-50. doi: 10.1159/000330563. Epub 2011 Aug 26.
23. Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes, a population-based study. Stroke. 2001 Dec 1;32(12):2735-40.
24. Mehndiratta P, Worrall BB, Chapman SS. Etiologic stroke subtypes: updated definition and efficient workup strategies. Curr Treat Options Cardiovasc Med. 2015 Jan;17(1):357. doi: 10.1007/s11936-014-0357-7.
25. Memon RA, Dahri AH, Memon S. Frequency and type of stroke in hypertensive patients. Medical Forum Monthly. 2011;22(10):31-34.
26. Bhalla A, Sankaralingam S, Dundas R, et al. Influence of Raised Plasma Osmolality on Clinical Outcome After Acute Stroke. Stroke. 2000 Sep;31(9):2043-8.
27. Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers. Stroke. 2008 Aug;39(8):2280-7. doi: 10.1161/STROKEAHA.107.505354. Epub 2008 Jun 5.
28. Wessler BS, Kent DM. Controversies in cardioembolic stroke. Curr Treat Options Cardiovasc Med. 2015 Jan;17(1):358. doi: 10.1007/s11936-014-0358-6.
29. Ershov VI, Chirkov AN. Algorithms for correction of water-electrolyte disorders in patients with severe ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2017;117(3/2): 31-4. (InRuss.)
30. Ershov VI, Chirkov AN. Hypervolemic hypernatremia in the onset of severe ischemic stroke as a predictor of adverse outcome. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116(6):10-3. (InRuss.)
Review
For citations:
Ershov VI, Chirkov AN, Gonchar-Zaykin AP, Lyashchenko SN, Lozinskaya TY, Gumalatova NV, Kuznetsov GE, Tenchurina LR. Mathematical modeling of ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):38-43. (In Russ.) https://doi.org/10.14412/2074-2711-2019-4-38-43